Pentadentate MRI Contrast Agent
Tech ID
P21-1250
Patent Status
Granted in India
Design Status
--
Technical Description
This invention presents a novel pent dentate chelate-based contrast agent for MRI, utilizing a new water-soluble ligand to enhance T1-weighted imaging. It aims to improve image contrast and diagnostic accuracy.
Problems Addressed
- Risky Nephrogenic Systemic Fibrosis(NSF) from Gd (III) ion leaching
- Manganese Toxicity issues
- Mn (II) CA withdrawal
- Coordination Complex Stability
TARGET AUDIENCE
- Medical Imaging Industry
- Pharmaceutical Industry
- Diagnostic Imaging Centre’s
- MRI Equipment Manufactures
- Biomedical Research Institutions
TECH FEATURES
- Piperidine-carboxylate ligand
- Provide novel metalcomplexes
- Water soluble Mn(II)complex
- Novel T1-weight MRI
P21-1250
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com